WellTheory, a digital health company addressing autoimmune disease, has raised $5 million in funding and has launched two new AI tools, the company announced Thursday.
Atherton, California-based WellTheory treats autoimmune conditions such as Addison’s disease, celiac disease, multiple sclerosis and lupus. Using a collaborative care model, it partners with patients’ physicians to deliver personalized plans focused on nutrition, stress, sleep and movement. The company offers video sessions, unlimited expert messaging and diagnostics. It serves both employers and health plans.
The $5 million raise included support from new investors Samsung Next, Opal Ventures and Up2 Fund, as well as existing investors Accel, OVO Fund and BoxGroup. In total, the company has raised $12 million.
The financing will help the company expand in the employer and health plan markets, as well as “accelerate the development of its AI-powered care infrastructure for both providers and members,” the announcement stated.
WellTheory also announced the rollout of two AI tools: Care Scribe and Care Hub. Care Scribe transcribes member sessions, drafts follow-up notes and creates care plans that are reviewed and can be customized by providers. Care Hub, meanwhile, aggregates member data, session history and lab insights and puts them in one place.
“Care delivery for patients with autoimmune disease is incredibly complex — our team built these tools to help give our Care Team time back for what matters most: supporting our members,” said Claire Rudolph, co-founder and head of product at WellTheory, in a statement. “With WellTheory’s Care Hub and Care Scribe, we’re building the modern infrastructure autoimmune care has always needed — intelligent, integrated systems that streamline repetitive tasks, amplify what makes care human, and equip our team to deliver more personalized, responsive support at scale.”
The funding and AI announcements come after WellTheory shared an outcomes report last month on its model. It found that the company’s model resulted in 81% of members reporting improved digestive symptoms, 55% reporting improvements in fatigue and 45% reporting improvements in pain.
The inspiration for WellTheory was born out of CEO and Co-founder Ellen Rudolph’s own experience finding care for her autoimmune condition. She experienced a list of unexplainable symptoms, including brain fog, gastrointestinal issues and fatigue, and was bedridden at 25 years old. She was dismissed by a variety of doctors, until she finally found answers via some lab results. She eventually went on to build WellTheory to help others with similar challenges.
During a recent interview at the Business Group on Health conference, Rudolph shared that the company’s upcoming priorities include building partnerships with employers and health plans, investing in AI and reducing administrative tasks for providers. In addition, the company hopes to create new health programs, similar to the women’s health program for hormonal conditions it launched in December.
“We see a lot of these comorbidities or kind of overlapping condition sets, for lack of a better word. So definitely more to come there,” she said.
Picture: Feodora Chiosea, Getty Images
